Robins M W
Department of Physiology, King's College, London, UK.
Calcif Tissue Int. 1990 Feb;46(2):94-100. doi: 10.1007/BF02556092.
Six groups of young adult, male mice were injected with six dose levels of the bone-seeking, alpha-emitting radionuclide 224Ra (half-life 3.6 days); a seventh group was injected with saline alone. The administered doses were relatively low, ranging from 2 to 64 kBq per animal. The mice were maintained under standard laboratory conditions until they either died or became moribund, when they were killed. The mean ages at death of the experimental groups were not significantly different from the normal control group. Individual bones--the mandible, parietal, nasal, and bulla--were isolated and standard linear measurements and dry weights were obtained. In all measurements considered, the highest two administered amounts (32 and 64 kBq) caused a significant reduction relative to controls. Low power microscopy of the mandible revealed osteonecrosis in the high dose groups. This is similar to the condition of "radium jaw" which has been described as a late effect of either accidental ingestion or therapeutic administration of 226Ra (half-life 1,620 years) in man; the other bones did not show obvious osteonecrosis. This work emphasizes the long-term osteopenic effects of low-dose radium, even in the short-lived species 224Ra. It also provides a method of quantifying the osteopenic effect of bone-seeking radionuclides.
将六组成年雄性小鼠注射六种剂量水平的亲骨性α发射放射性核素224Ra(半衰期3.6天);第七组仅注射生理盐水。给药剂量相对较低,每只动物为2至64 kBq。小鼠在标准实验室条件下饲养,直至死亡或濒死时处死。实验组的平均死亡年龄与正常对照组无显著差异。分离出个别骨骼——下颌骨、顶骨、鼻骨和中耳泡——并进行标准线性测量和获取干重。在所有考虑的测量中,最高的两个给药量(32和64 kBq)相对于对照组导致显著降低。下颌骨的低倍显微镜检查显示高剂量组存在骨坏死。这与“镭颌骨症”的情况相似,“镭颌骨症”被描述为人类意外摄入或治疗性施用226Ra(半衰期1620年)的晚期效应;其他骨骼未显示明显的骨坏死。这项工作强调了低剂量镭的长期骨质减少效应,即使是在半衰期短的224Ra物种中。它还提供了一种量化亲骨性放射性核素骨质减少效应的方法。